ADC Therapeutics SA (ADCT) Enters Development and License Option Agreement with IntoCell streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ IntoCell today announced the signing of a Material Transfer Agreement (MTA) with option to license with ADC Therapeutics SA (NYSE: ADCT). Under.
London-based deal experts are the advisors for this collaboration and the ongoing partnering efforts for IntoCell's platform technologies and its lead programme, B7-H3 ADC. LONDON, Jan.
Bio-chromatography company Sartorius BIA Separations (Ajdovšcina, Slovenia) and Exopharm Ltd (Melbourne) have signed a Material Transfer Agreement and associated collaborative programme aiming to combine the Australian company’s LEAP technology with Convective Interaction Media (CIM) monolith chromatography for improved large-scale therapeutic exosome production and commercialisation. Click to read more.